Anxiety and depression are highly prevalent in people with rheumatoid arthritis (RA).This study is to investigate the effect of anxiety and depression on treatment response in people with RA using observational longitudinal study design.
Study Type
OBSERVATIONAL
Enrollment
134
The presence of anxiety or depression measured by the Hospital Anxiety and Depression Scale (HAD)
Clinical remission
Clinical remission defined by the Disease Activity Score 28 (DAS28) with a score less than 2.6
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.